Seminars in Radiation Oncology
Volume 17, Issue 3 , Pages 176-183, July 2007

Radioimmunotherapy as a Therapeutic Option for Non-Hodgkin’s Lymphoma

  • Roger M. Macklis, MD

      Affiliations

    • Roger Macklis has received honoraria for teaching and lecturing from Biogen-IDEC and Glaxo-Smith-Kline. Biogen-IDEC has also contributed financial support to the Cleveland Clinic for his investigator-initiated clinical trials in the area of radioimmunotherapy. He has no equity in any involved commercial concern.
    • Corresponding Author InformationAddress reprint requests to Roger M. Macklis, MD, Department of Radiation Oncology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk T28, Cleveland, OH 44195.

Cleveland Clinic Lerner College of Medicine and Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1053-4296(07)00014-8

doi:10.1016/j.semradonc.2007.02.003

Seminars in Radiation Oncology
Volume 17, Issue 3 , Pages 176-183, July 2007

Article Tools

* Image Usage & Resolution